Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
ESMO 2019
Asia
Sanofi cuts, CEOs' Chinese names and more—FiercePharmaAsia
Sanofi slims down in Japan. We examine Big Pharma CEOs' Chinese names. Positive data came out from Astellas, Eisai and Chi-Med at ESMO.
Angus Liu
Oct 4, 2019 10:00am
GSK, AZ-Merck PARP data heap pressure on Clovis: analysts
Oct 2, 2019 11:28am
ESMO may be over, but these market battles are just beginning
Oct 1, 2019 10:47am
Agios celebrates milestone win in hard-to-treat bile duct cancer
Sep 30, 2019 10:30am
Roche's Tecentriq-chemo duo edges past chemo in bladder cancer
Sep 30, 2019 10:30am
AZ, Merck's Lynparza posts 'game-changer' prostate cancer data
Sep 30, 2019 10:30am
